Pneumococcal Vaccine (ÖIP)
Original notice title
Austria – Vaccines – Pneumokokken-Impfstoff (ÖIP)
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
No estimated contract value is provided, making it impossible to assess financial attractiveness or resource commitment.
Award criteria are not defined, creating uncertainty in how tenders will be evaluated.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration 36 MONTH
- Supply of 21-valent pneumococcal conjugate vaccine for adults in pre-filled syringe.
- Vaccine must have a valid Austrian marketing authorization under the Austrian Medicines Act (AMG) or equivalent EU regulations.
Show full summary
This tender is for a framework agreement for the supply of a 21-valent pneumococcal conjugate vaccine for adults (in pre-filled syringe with Austrian marketing authorization) to the Austrian Immunization Program (ÖIP) and other public buyers. The tender is an open procedure with one lot, electronic submission required, and a 36-month duration. No estimated value or award criteria are provided, and the notice contains conflicting EU funding information.
Risks
No estimated contract value is provided, making it impossible to assess financial attractiveness or resource commitment.
Award criteria are not defined, creating uncertainty in how tenders will be evaluated.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Tenderers must be able to supply a 21-valent pneumococcal conjugate vaccine for adults.
- Vaccine must be supplied in a pre-filled syringe.
- Austrian marketing authorization must be in place.
Award Criteria
Lot 1
Buyer
Location
Wien, AUT
Website
Buyer profile
Identifier
210220y
Activity
Economic affairs
Lots (1)
LOT-0001
Pneumococcal Vaccine (ÖIP)
Supply of 21-valent pneumococcal conjugate vaccine for adults in pre-filled syringe, with Austrian marketing authorization, for the ÖIP and public buyers under a framework agreement.
Location
Duration
Category
Award Criteria
Deadline
Award details
Gegenstand dieser Rahmenvereinbarung ist die Lieferung von Pneumokokken-Impfstoffen (21-valenter Konjugatimpfstoff) für Erwachsene in Form einer Fertigspritze jeweils mit einer in Österreich gültigen Arzneimittelzulassung gemäß österreichischem Arzneimittelgesetz (AMG) idgF. (inkl. österreichischer Verordnungen) bzw. zu Grunde liegender EU-Rechtsnormen sowie die Auslieferung der Impfstoffe für das ÖIP sowie für öffentliche Auftraggeber.
Value note
Show original TED data
Original lot title
Pneumokokken-Impfstoff (ÖIP)
Original TED description
Gegenstand dieser Rahmenvereinbarung ist die Lieferung von Pneumokokken-Impfstoffen (21-valenter Konjugatimpfstoff) für Erwachsene in Form einer Fertigspritze jeweils mit einer in Österreich gültigen Arzneimittelzulassung gemäß österreichischem Arzneimittelgesetz (AMG) idgF. (inkl. österreichischer Verordnungen) bzw. zu Grunde liegender EU-Rechtsnormen sowie die Auslieferung der Impfstoffe für das ÖIP sowie für öffentliche Auftraggeber.
Procurement Details
- Publication date
- 07 Jul 2026
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 468926-2026
Documents (1)
Similar tenders
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
30 / 100
Risk factors
No estimated contract value is provided, making it impossible to assess financial attractiveness or resource commitment.
Award criteria are not defined, creating uncertainty in how tenders will be evaluated.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications